Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma.

Clinical Sarcoma Research
Daniela KatzDejka M Araujo

Abstract

Myxoid liposarcoma (MLS) is a soft tissue sarcoma with adipocytic differentiation characterized by a unique chromosome rearrangement, t(12;16)(q13;p11). The exact efficacy of chemotherapy in MLS has not been clearly established. We retrospectively analyzed the records of 37 histologically confirmed MLS patients who were treated at the University of Texas MD Anderson Cancer Center from January 2000 to December 2009 with doxorubicin 75-90 mg/m2 over 72 hours combined with ifosfamide 10 gm/m2 in the first-line setting. Response was assessed using RECIST and Choi criteria. The Kaplan-Meier method and log-rank test was used to estimate clinical outcomes. The median follow-up period was 50.1 months. The overall response rates were 43.2% using RECIST and 86.5% using the Choi criteria. The 5-year disease-free survival rate was 90% for patients with resectable tumors. Median time to progression and overall survival time for the advanced-disease group were 23 and 31.1 months, respectively. Our study demonstrates that doxorubicin-ifosfamide combination therapy has a role in the treatment of MLS. The Choi criteria may be more sensitive in evaluating response to chemotherapy in MLS.

References

Dec 1, 1979·The American Journal of Surgical Pathology·H L Evans
May 1, 1977·Cancer·R M O'BryanB Hoogstraten
Apr 1, 1990·Annals of Surgery·C M PezziM M Romsdahl
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S R PatelR S Benjamin
Sep 26, 2007·International Journal of Radiation Oncology, Biology, Physics·B Ashleigh GuadagnoloRaphael E Pollock
Dec 22, 2007·Skeletal Radiology·Kenneth SheahMiriam A Bredella
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alessandro GronchiPaolo G Casali
May 13, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carolyn D SeibBrent T Shoji
Jun 29, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Martin P PowersDolores H López-Terrada

❮ Previous
Next ❯

Citations

Jan 9, 2014·Expert Review of Anticancer Therapy·Attila Kollár, Charlotte Benson
Feb 15, 2014·Expert Review of Anticancer Therapy·Aisha B MiahDirk C Strauss
May 10, 2013·Expert Review of Anticancer Therapy·Roberta Sanfilippo, Paolo G Casali
Oct 8, 2013·Hematology/oncology Clinics of North America·Joern Henze, Sebastian Bauer
Oct 15, 2014·Cancer·Sant P ChawlaDaniel J Levitt
Feb 11, 2015·Clinical Sarcoma Research·Marco MaruzzoCharlotte Benson
Feb 12, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jean-Yves BlaySant P Chawla
May 14, 2016·International Journal of Surgery Case Reports·S Navin NoushadSubbiah Shanmugam
Jun 9, 2016·Laboratory Investigation; a Journal of Technical Methods and Pathology·Marieke A de GraaffNeeta Somaiah
Mar 29, 2018·World Journal of Surgical Oncology·Hiroshi UrakawaYoshihiro Nishida
Oct 5, 2017·Therapeutic Advances in Medical Oncology·Jenna S BlelochSharon Prince
Jan 21, 2017·F1000Research·Nadar A NassifBurton Eisenberg
Jan 17, 2019·International Journal of Cancer. Journal International Du Cancer·Soheila DolatabadiAnders Ståhlberg
Dec 2, 2017·Journal of Surgical Oncology·Anastasia Constantinidou, Robin L Jones
Oct 18, 2018·NMC Case Report Journal·Yuta MurakamiKiyoshi Saito
Dec 6, 2018·Sarcoma·Varun ChowdhryKaren De Amorim Bernstein
Sep 21, 2018·American Society of Clinical Oncology Educational Book·Daniela KatzSeth M Pollack
May 16, 2013·Current Opinion in Oncology·Roberta SanfilippoPaolo G Casali
Apr 18, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenneth R GundleRobert G Maki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.